INDEGENE
Quarterly Results Analysis [Jun2025]
INDEGENE Quarterly Results
Consolidated | Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹761 Cr | ₹756 Cr | ₹720 Cr | ₹687 Cr | ₹677 Cr | ₹673 Cr | ₹673 Cr | ₹636 Cr |
Expenses | ₹606 Cr | ₹608 Cr | ₹589 Cr | ₹561 Cr | ₹548 Cr | ₹534 Cr | ₹525 Cr | ₹515 Cr |
Operating Income | ₹155 Cr | ₹148 Cr | ₹132 Cr | ₹126 Cr | ₹129 Cr | ₹139 Cr | ₹149 Cr | ₹121 Cr |
Other Income | ₹22 Cr | ₹26 Cr | ₹38 Cr | ₹21 Cr | ₹23 Cr | ₹23 Cr | ₹13 Cr | ₹12 Cr |
Interest | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
Depreciation | ₹22 Cr | ₹21 Cr | ₹20 Cr | ₹19 Cr | ₹20 Cr | ₹19 Cr | ₹18 Cr | ₹20 Cr |
Profit Before Tax | ₹152 Cr | ₹149 Cr | ₹146 Cr | ₹124 Cr | ₹120 Cr | ₹134 Cr | ₹132 Cr | ₹101 Cr |
Profit After Tax | ₹116 Cr | ₹118 Cr | ₹110 Cr | ₹92 Cr | ₹88 Cr | ₹95 Cr | ₹99 Cr | ₹75 Cr |
EPS | ₹4.86 | ₹4.91 | ₹4.59 | ₹3.84 | ₹3.66 | ₹4.27 | ₹4.45 | ₹3.39 |
Industry Peers & Returns | 1W | 1M | 1Y |
INDEGENE | 5.3% | 1.8% | -10.7% |
SUN PHARMACEUTICAL INDUSTRIES | -4.3% | -3% | -0.7% |
DIVIS LABORATORIES | -3.3% | -7.4% | 34.1% |
CIPLA | -4.4% | -0.5% | 0.7% |
TORRENT PHARMACEUTICALS | 1.4% | 10.1% | 17.9% |
DR REDDYS LABORATORIES | -5.2% | -5.7% | -5.9% |
MANKIND PHARMA | 0.8% | 8.4% | 26.4% |
ZYDUS LIFESCIENCES | -3.1% | -5.1% | -22.2% |
LUPIN | -4.9% | -4.6% | 0.9% |
INDEGENE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 0.69 % |
Y-o-Y | 12.46 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2025 | ₹761 Cr | 0.69 | |
Mar2025 | ₹756 Cr | 4.89 | |
Dec2024 | ₹720 Cr | 4.89 | |
Sep2024 | ₹687 Cr | 1.52 | |
Jun2024 | ₹677 Cr | 0.52 | |
Mar2024 | ₹673 Cr | -0.06 | |
Dec2023 | ₹673 Cr | 5.93 | |
Sep2023 | ₹636 Cr | - |
INDEGENE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 5.29 % |
Y-o-Y | 20.48 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2025 | ₹155 Cr | 5.29 | |
Mar2025 | ₹148 Cr | 11.91 | |
Dec2024 | ₹132 Cr | 4.52 | |
Sep2024 | ₹126 Cr | -2.17 | |
Jun2024 | ₹129 Cr | -7.07 | |
Mar2024 | ₹139 Cr | -6.85 | |
Dec2023 | ₹149 Cr | 22.96 | |
Sep2023 | ₹121 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 4.56 % |
Y-o-Y | 7.14 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2025 | 20.41% | 4.56 | |
Mar2025 | 19.52% | 6.67 | |
Dec2024 | 18.3% | -0.33 | |
Sep2024 | 18.36% | -3.62 | |
Jun2024 | 19.05% | -7.57 | |
Mar2024 | 20.61% | -6.78 | |
Dec2023 | 22.11% | 16.06 | |
Sep2023 | 19.05% | - |
INDEGENE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -1.02 % |
Y-o-Y | 32.73 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2025 | ₹116 Cr | -1.02 | |
Mar2025 | ₹118 Cr | 7.20 | |
Dec2024 | ₹110 Cr | 19.63 | |
Sep2024 | ₹92 Cr | 4.56 | |
Jun2024 | ₹88 Cr | -7.49 | |
Mar2024 | ₹95 Cr | -4.05 | |
Dec2023 | ₹99 Cr | 31.73 | |
Sep2023 | ₹75 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -1.67 % |
Y-o-Y | 18.06 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2025 | 15.3 % | -1.67 | |
Mar2025 | 15.56 % | 2.17 | |
Dec2024 | 15.23 % | 14.08 | |
Sep2024 | 13.35 % | 3.01 | |
Jun2024 | 12.96 % | -8.02 | |
Mar2024 | 14.09 % | -3.95 | |
Dec2023 | 14.67 % | 24.32 | |
Sep2023 | 11.8 % | - |
INDEGENE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -1.02 % |
Y-o-Y | 32.79 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2025 | ₹4.86 | -1.02 | |
Mar2025 | ₹4.91 | 6.97 | |
Dec2024 | ₹4.59 | 19.53 | |
Sep2024 | ₹3.84 | 4.92 | |
Jun2024 | ₹3.66 | -14.29 | |
Mar2024 | ₹4.27 | -4.04 | |
Dec2023 | ₹4.45 | 31.27 | |
Sep2023 | ₹3.39 | - |
You may also like the below Video Courses